Detalles de la búsqueda
1.
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Oncologist;
28(10): 875-884, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676712
2.
Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically.
Oncology;
101(11): 723-729, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379817
3.
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.
Eur J Clin Pharmacol;
79(2): 243-248, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36520173
4.
The Relationship between Nutritional Parameters and Thrombosis Risk in Cancer Patients.
Nutr Cancer;
74(4): 1370-1375, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309454
5.
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.
Future Oncol;
18(23): 2573-2582, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35734870
6.
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.
Int J Gynecol Cancer;
32(4): 502-507, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35086927
7.
Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastases.
Future Oncol;
17(13): 1611-1624, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33631986
8.
Fertility in testicular cancer patients: a single-centre study in Turkey.
Int J Clin Oncol;
25(3): 495-500, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31452020
9.
Correction to: Fertility in testicular cancer patients: a singlecentre study in Turkey.
Int J Clin Oncol;
25(3): 501, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31797189
10.
Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.
Tumour Biol;
35(12): 11871-7, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25142230
11.
The effect of autoimmunity on the development time of microvascular complications in patients with type 1 diabetes mellitus.
Med Sci Monit;
20: 1176-9, 2014 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25007947
12.
Prognostic significance of tumor budding, desmoplastic reaction, and lymphocytic infiltration in patients with gastric adenocarcinoma.
World J Gastrointest Pathophysiol;
15(1): 91237, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38682027
13.
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Sci Rep;
14(1): 5820, 2024 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38461209
14.
The effect of using adjuvant aromatase inhibitors on cognitive functions in postmenopausal women with hormone receptor-positive breast cancer.
J Cancer Res Ther;
19(Supplement): S0, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37147957
15.
The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.
J Cancer Res Clin Oncol;
149(11): 9183-9189, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37184681
16.
Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?
J Cancer Res Clin Oncol;
149(14): 13271-13277, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480524
17.
Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study.
J Cancer Res Clin Oncol;
149(2): 865-875, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35381885
18.
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study).
J Cancer Res Clin Oncol;
149(8): 4141-4148, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36048274
19.
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group.
Medicine (Baltimore);
101(50): e32368, 2022 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36550824
20.
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study.
J Cancer Res Clin Oncol;
148(6): 1501-1508, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34331582